Keybanc Maintains Overweight on Progyny, Raises Price Target to $50
Portfolio Pulse from richadhand@benzinga.com
Keybanc analyst Scott Schoenhaus has maintained an Overweight rating on Progyny (NASDAQ:PGNY) and raised the price target from $45 to $50.
August 04, 2023 | 2:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Progyny's price target has been raised from $45 to $50 by Keybanc, maintaining an Overweight rating.
The raised price target and maintained Overweight rating by Keybanc indicates a positive outlook for Progyny. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100